| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.1 | 0.01 |